After her 2005 diagnosis with osteoporosis, Sally Field launched the 'Rally with Sally for Bone Health' campaign to raise awareness about early diagnosis and prevention, promoting bone-density scans and lifestyle measures. The effort, however, became controversial because it was supported by pharmaceutical companies Roche and GlaxoSmithKline and was criticized for co-promoting Boniva, a bisphosphonate treatment marketed by one of those companies. Critics and some patient-advocacy observers questioned whether the campaign blurred the line between public health education and pharmaceutical marketing, creating a perceived conflict of interest for a beloved public figure. Field's campaign nevertheless helped raise awareness of bone health while also prompting discussions about celebrity advocacy and industry funding for public-health initiatives.
Preparing the daily feature…
AI concept artworkArchive Record · 2000s
Rally with Sally: An Osteoporosis Campaign That Sparked Questions About Pharma Co‑Promotion
Sally Field / Rally with Sally / 2000s
After her 2005 diagnosis with osteoporosis, Sally Field launched the 'Rally with Sally for Bone Health' campaign to raise awareness about early diagnosis and prevention, promoting bone-density scans and lifestyle measures. The effort, however, became controversial because it was supported by pharmaceutical companies Roche and GlaxoSmithKline and was criticized for co-promoting Boniva, a bisphosphonate treatment marketed by one of those companies. Critics and some patient-advocacy observers questioned whether the campaign blurred the line between public health education and pharmaceutical marketing, creating a perceived conflict of interest for a beloved public figure. Field's campaign nevertheless helped raise awareness of bone health while also prompting discussions about celebrity advocacy and industry funding for public-health initiatives.
The daily feature is taking an intermission. There’s still an entire archive to explore.